Filing metadata

Accession number
0001209191-21-047387
Form type
Form 3
Filer
Janux Therapeutics, Inc.
CIK
CIK 1817713
Filed
Jul 20, 2021
Reporting period
Jul 12, 2021
Description
Initial ownership

Explore SEC Filings Hub